title: Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment.
abstract: Pituitary metastasis from renal cell carcinoma is rare and has never been reported for renal cell carcinoma primarily treated with sorafenib. Herein, we present a case of an advanced clear-cell renal cell carcinoma in which pituitary metastasis progressed but extracerebral metastases showed partial response to sorafenib treatment.
authors.affiliation: Huazhong Science and Technology University, Wuhan, Hubei, People's Republic of China.
authors.forename: Lin
authors.initials: L
authors.lastname: Yang
authors.forename: Shi-Ying
authors.initials: SY
authors.lastname: Yu
authors.forename: Guang-Yuan
authors.initials: GY
authors.lastname: Hu
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000532:radiotherapy / Q000556:secondary*; D020266:Radiotherapy, Conformal; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib